ICD-10-CM/PCS MS-DRG v41.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
DRAFT
ICD-10-CM/PCS MS-DRG v41.0 Definitions Manual |
> | |||
| Skip to content | |
|
|
| Appendix C: Principal diagnoses which convert CC/MCC to non-CC |
| Page 1175 of 1375 |
| PDX Collection 6276 (continued) | |
| J661 | Flax-dressers' disease |
| J662 | Cannabinosis |
| J668 | Airway disease due to other specific organic dusts |
| J670 | Farmer's lung |
| J671 | Bagassosis |
| J672 | Bird fancier's lung |
| J673 | Suberosis |
| J674 | Maltworker's lung |
| J675 | Mushroom-worker's lung |
| J676 | Maple-bark-stripper's lung |
| J677 | Air conditioner and humidifier lung |
| J678 | Hypersensitivity pneumonitis due to other organic dusts |
| J679 | Hypersensitivity pneumonitis due to unspecified organic dust |
| J680 | Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors |
| J681 | Pulmonary edema due to chemicals, gases, fumes and vapors |
| J682 | Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified |
| J683 | Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors |
| J684 | Chronic respiratory conditions due to chemicals, gases, fumes and vapors |
| J688 | Other respiratory conditions due to chemicals, gases, fumes and vapors |
| J689 | Unspecified respiratory condition due to chemicals, gases, fumes and vapors |
| J690 | Pneumonitis due to inhalation of food and vomit |
| J691 | Pneumonitis due to inhalation of oils and essences |
| J698 | Pneumonitis due to inhalation of other solids and liquids |
| J700 | Acute pulmonary manifestations due to radiation |
| J701 | Chronic and other pulmonary manifestations due to radiation |
| J702 | Acute drug-induced interstitial lung disorders |
| J703 | Chronic drug-induced interstitial lung disorders |
| J704 | Drug-induced interstitial lung disorders, unspecified |
| J708 | Respiratory conditions due to other specified external agents |
| J709 | Respiratory conditions due to unspecified external agent |
| J984 | Other disorders of lung |
| J988 | Other specified respiratory disorders |
| J989 | Respiratory disorder, unspecified |
| J99 | Respiratory disorders in diseases classified elsewhere |
| N80B1 | Endometriosis of pleura |
| N80B2 | Endometriosis of lung |
| N80B31 | Superficial endometriosis of diaphragm |
| N80B32 | Deep endometriosis of diaphragm |
| N80B39 | Endometriosis of diaphragm, unspecified depth |
| Q334 | Congenital bronchiectasis |
| R911 | Solitary pulmonary nodule |
| PDX Collection 6277 | |
| D800 | Hereditary hypogammaglobulinemia |
| D803 | Selective deficiency of immunoglobulin G [IgG] subclasses |
| D804 | Selective deficiency of immunoglobulin M [IgM] |
| D805 | Immunodeficiency with increased immunoglobulin M [IgM] |
| D806 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
| D807 | Transient hypogammaglobulinemia of infancy |
| D808 | Other immunodeficiencies with predominantly antibody defects |
| D809 | Immunodeficiency with predominantly antibody defects, unspecified |
| D810 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D811 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D812 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D814 | Nezelof's syndrome |
| D816 | Major histocompatibility complex class I deficiency |
| D817 | Major histocompatibility complex class II deficiency |
| D8182 | Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D8189 | Other combined immunodeficiencies |
| D819 | Combined immunodeficiency, unspecified |
| D820 | Wiskott-Aldrich syndrome |
| D821 | Di George's syndrome |
| D822 | Immunodeficiency with short-limbed stature |
| D823 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| D824 | Hyperimmunoglobulin E [IgE] syndrome |
| D828 | Immunodeficiency associated with other specified major defects |
| D829 | Immunodeficiency associated with major defect, unspecified |
| D830 | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D831 | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
| D832 | Common variable immunodeficiency with autoantibodies to B- or T-cells |
| D838 | Other common variable immunodeficiencies |
| D839 | Common variable immunodeficiency, unspecified |
| D840 | Lymphocyte function antigen-1 [LFA-1] defect |
| D8481 | Immunodeficiency due to conditions classified elsewhere |
| D84821 | Immunodeficiency due to drugs |
| D84822 | Immunodeficiency due to external causes |
| D8489 | Other immunodeficiencies |
| D849 | Immunodeficiency, unspecified |
| D893 | Immune reconstitution syndrome |
| D8940 | Mast cell activation, unspecified |
| D8941 | Monoclonal mast cell activation syndrome |
| D8942 | Idiopathic mast cell activation syndrome |
| D8943 | Secondary mast cell activation |
| D8949 | Other mast cell activation disorder |
| D8982 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D8984 | IgG4-related disease |
| D8989 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D899 | Disorder involving the immune mechanism, unspecified |
| PDX Collection 6278 | |
| A021 | Salmonella sepsis |
| A207 | Septicemic plague |
| A227 | Anthrax sepsis |
| A267 | Erysipelothrix sepsis |
| A327 | Listerial sepsis |
| A392 | Acute meningococcemia |
| A393 | Chronic meningococcemia |
| A394 | Meningococcemia, unspecified |
| A400 | Sepsis due to streptococcus, group A |
| A401 | Sepsis due to streptococcus, group B |
| A408 | Other streptococcal sepsis |
| A409 | Streptococcal sepsis, unspecified |
| A4101 | Sepsis due to Methicillin susceptible Staphylococcus aureus |
| A4102 | Sepsis due to Methicillin resistant Staphylococcus aureus |
| A411 | Sepsis due to other specified staphylococcus |
| A412 | Sepsis due to unspecified staphylococcus |
| A413 | Sepsis due to Hemophilus influenzae |
| A414 | Sepsis due to anaerobes |
| A4150 | Gram-negative sepsis, unspecified |
| A4151 | Sepsis due to Escherichia coli [E. coli] |
| A4152 | Sepsis due to Pseudomonas |
| A4153 | Sepsis due to Serratia |
| A4154 | Sepsis due to Acinetobacter baumannii |
| A4159 | Other Gram-negative sepsis |
| A4181 | Sepsis due to Enterococcus |
| A4189 | Other specified sepsis |
| A419 | Sepsis, unspecified organism |
| A427 | Actinomycotic sepsis |
| A482 | Nonpneumonic Legionnaires' disease [Pontiac fever] |
| A483 | Toxic shock syndrome |
| A484 | Brazilian purpuric fever |
| A488 | Other specified bacterial diseases |
| A4901 | Methicillin susceptible Staphylococcus aureus infection, unspecified site |
| A4902 | Methicillin resistant Staphylococcus aureus infection, unspecified site |
| A491 | Streptococcal infection, unspecified site |
| A492 | Hemophilus influenzae infection, unspecified site |
| A493 | Mycoplasma infection, unspecified site |
| A498 | Other bacterial infections of unspecified site |
| A499 | Bacterial infection, unspecified |
| A5486 | Gonococcal sepsis |
| B007 | Disseminated herpesviral disease |
| B377 | Candidal sepsis |
| B92 | Sequelae of leprosy |
| B942 | Sequelae of viral hepatitis |
| B948 | Sequelae of other specified infectious and parasitic diseases |
| B949 | Sequelae of unspecified infectious and parasitic disease |
| B950 | Streptococcus, group A, as the cause of diseases classified elsewhere |
| B951 | Streptococcus, group B, as the cause of diseases classified elsewhere |
| B952 | Enterococcus as the cause of diseases classified elsewhere |
| B953 | Streptococcus pneumoniae as the cause of diseases classified elsewhere |
| B954 | Other streptococcus as the cause of diseases classified elsewhere |
| B955 | Unspecified streptococcus as the cause of diseases classified elsewhere |
| B9561 | Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B9562 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere |
| B957 | Other staphylococcus as the cause of diseases classified elsewhere |
| B958 | Unspecified staphylococcus as the cause of diseases classified elsewhere |
| B960 | Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere |
| B961 | Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere |
| B9620 | Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
| B9621 | Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere |
| B9622 | Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
| B9623 | Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere |
| B9629 | Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere |
| B963 | Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere |
| B964 | Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere |
| B965 | Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere |
| B966 | Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere |
| B967 | Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere |
| B9681 | Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere |
| B9682 | Vibrio vulnificus as the cause of diseases classified elsewhere |
| B9689 | Other specified bacterial agents as the cause of diseases classified elsewhere |
| R6510 | Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction |
| R6511 | Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction |
| R6520 | Severe sepsis without septic shock |
| Z1610 | Resistance to unspecified beta lactam antibiotics |
| Z1611 | Resistance to penicillins |
| Z1612 | Extended spectrum beta lactamase (ESBL) resistance |
| Z1619 | Resistance to other specified beta lactam antibiotics |
| Z1620 | Resistance to unspecified antibiotic |
| Z1621 | Resistance to vancomycin |
| Z1622 | Resistance to vancomycin related antibiotics |
| Z1623 | Resistance to quinolones and fluoroquinolones |
| Z1624 | Resistance to multiple antibiotics |
| Z1629 | Resistance to other single specified antibiotic |
| Z1630 | Resistance to unspecified antimicrobial drugs |
| Z1631 | Resistance to antiparasitic drug(s) |
| Z1632 | Resistance to antifungal drug(s) |
| Z1633 | Resistance to antiviral drug(s) |
| Z16341 | Resistance to single antimycobacterial drug |
| Z16342 | Resistance to multiple antimycobacterial drugs |
| Z1635 | Resistance to multiple antimicrobial drugs |
| Z1639 | Resistance to other specified antimicrobial drug |
| PDX Collection 6279 | |
| G3289 | Other specified degenerative disorders of nervous system in diseases classified elsewhere |
| G40001 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus |
| G40009 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus |
| G40011 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus |
| G40019 | Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus |
| G40101 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus |
| G40109 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus |
| G40111 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus |
| G40119 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus |
| G40201 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus |
| G40209 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus |
| G40211 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus |
| G40219 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus |
| G40301 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40309 | Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40311 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40319 | Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G40401 | Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus |
| G40409 | Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus |
| G40411 | Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus |
| G40419 | Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus |
| G4042 | Cyclin-Dependent Kinase-Like 5 Deficiency Disorder |
| G40501 | Epileptic seizures related to external causes, not intractable, with status epilepticus |
| G40509 | Epileptic seizures related to external causes, not intractable, without status epilepticus |
| G40801 | Other epilepsy, not intractable, with status epilepticus |
| G40802 | Other epilepsy, not intractable, without status epilepticus |
| G40803 | Other epilepsy, intractable, with status epilepticus |
| G40804 | Other epilepsy, intractable, without status epilepticus |
| G40811 | Lennox-Gastaut syndrome, not intractable, with status epilepticus |
| G40812 | Lennox-Gastaut syndrome, not intractable, without status epilepticus |
| G40813 | Lennox-Gastaut syndrome, intractable, with status epilepticus |
| G40814 | Lennox-Gastaut syndrome, intractable, without status epilepticus |
| G40821 | Epileptic spasms, not intractable, with status epilepticus |
| G40822 | Epileptic spasms, not intractable, without status epilepticus |
| G40823 | Epileptic spasms, intractable, with status epilepticus |
| G40824 | Epileptic spasms, intractable, without status epilepticus |
| G40833 | Dravet syndrome, intractable, with status epilepticus |
| G40834 | Dravet syndrome, intractable, without status epilepticus |
| G4089 | Other seizures |
| G40901 | Epilepsy, unspecified, not intractable, with status epilepticus |
| G40909 | Epilepsy, unspecified, not intractable, without status epilepticus |
| G40911 | Epilepsy, unspecified, intractable, with status epilepticus |
| G40919 | Epilepsy, unspecified, intractable, without status epilepticus |
| G40A01 | Absence epileptic syndrome, not intractable, with status epilepticus |
| G40A09 | Absence epileptic syndrome, not intractable, without status epilepticus |
| G40A11 | Absence epileptic syndrome, intractable, with status epilepticus |
| G40A19 | Absence epileptic syndrome, intractable, without status epilepticus |
| G40B01 | Juvenile myoclonic epilepsy, not intractable, with status epilepticus |
| G40B09 | Juvenile myoclonic epilepsy, not intractable, without status epilepticus |
| G40B11 | Juvenile myoclonic epilepsy, intractable, with status epilepticus |
| G40B19 | Juvenile myoclonic epilepsy, intractable, without status epilepticus |
| G40C01 | Lafora progressive myoclonus epilepsy, not intractable, with status epilepticus |
| G40C09 | Lafora progressive myoclonus epilepsy, not intractable, without status epilepticus |
| G40C11 | Lafora progressive myoclonus epilepsy, intractable, with status epilepticus |
| G40C19 | Lafora progressive myoclonus epilepsy, intractable, without status epilepticus |
| G9340 | Encephalopathy, unspecified |
| G9341 | Metabolic encephalopathy |
| G9342 | Megaloencephalic leukoencephalopathy with subcortical cysts |
| G9343 | Leukoencephalopathy with calcifications and cysts |
| G9344 | Adult-onset leukodystrophy with axonal spheroids |
| G9349 | Other encephalopathy |
| G939 | Disorder of brain, unspecified |
| G969 | Disorder of central nervous system, unspecified |
| G980 | Neurogenic arthritis, not elsewhere classified |
| G988 | Other disorders of nervous system |
| G998 | Other specified disorders of nervous system in diseases classified elsewhere |
| I6783 | Posterior reversible encephalopathy syndrome |
| R561 | Post traumatic seizures |
| PDX Collection 6280 | |
| D800 | Hereditary hypogammaglobulinemia |
| D803 | Selective deficiency of immunoglobulin G [IgG] subclasses |
| D804 | Selective deficiency of immunoglobulin M [IgM] |
| D805 | Immunodeficiency with increased immunoglobulin M [IgM] |
| D806 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
| D807 | Transient hypogammaglobulinemia of infancy |
| D808 | Other immunodeficiencies with predominantly antibody defects |
| D809 | Immunodeficiency with predominantly antibody defects, unspecified |
| D810 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D811 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D812 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D814 | Nezelof's syndrome |
| D816 | Major histocompatibility complex class I deficiency |
| D817 | Major histocompatibility complex class II deficiency |
| D8182 | Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D8189 | Other combined immunodeficiencies |
| D819 | Combined immunodeficiency, unspecified |
| D820 | Wiskott-Aldrich syndrome |
| D821 | Di George's syndrome |
| D822 | Immunodeficiency with short-limbed stature |
| D823 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| D824 | Hyperimmunoglobulin E [IgE] syndrome |
| D828 | Immunodeficiency associated with other specified major defects |
| D829 | Immunodeficiency associated with major defect, unspecified |
| D830 | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D831 | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
| D832 | Common variable immunodeficiency with autoantibodies to B- or T-cells |
| D838 | Other common variable immunodeficiencies |
| D839 | Common variable immunodeficiency, unspecified |
| D840 | Lymphocyte function antigen-1 [LFA-1] defect |
| D8481 | Immunodeficiency due to conditions classified elsewhere |
| D84821 | Immunodeficiency due to drugs |
| D84822 | Immunodeficiency due to external causes |
| D8489 | Other immunodeficiencies |
| D849 | Immunodeficiency, unspecified |
| D893 | Immune reconstitution syndrome |
| D8940 | Mast cell activation, unspecified |
| D8941 | Monoclonal mast cell activation syndrome |
| D8942 | Idiopathic mast cell activation syndrome |
| D8943 | Secondary mast cell activation |
| D8949 | Other mast cell activation disorder |
| D8982 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D8984 | IgG4-related disease |
| D8989 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D899 | Disorder involving the immune mechanism, unspecified |
| PDX Collection 6281 | |
| D800 | Hereditary hypogammaglobulinemia |
| D803 | Selective deficiency of immunoglobulin G [IgG] subclasses |
| D804 | Selective deficiency of immunoglobulin M [IgM] |
| D805 | Immunodeficiency with increased immunoglobulin M [IgM] |
| D806 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
| D807 | Transient hypogammaglobulinemia of infancy |
| D808 | Other immunodeficiencies with predominantly antibody defects |
| D809 | Immunodeficiency with predominantly antibody defects, unspecified |
| D810 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D811 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D812 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D814 | Nezelof's syndrome |
| D816 | Major histocompatibility complex class I deficiency |
| D817 | Major histocompatibility complex class II deficiency |
| D8182 | Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D8189 | Other combined immunodeficiencies |
| D819 | Combined immunodeficiency, unspecified |
| D820 | Wiskott-Aldrich syndrome |
| D821 | Di George's syndrome |
| D822 | Immunodeficiency with short-limbed stature |
| D823 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| D824 | Hyperimmunoglobulin E [IgE] syndrome |
| D828 | Immunodeficiency associated with other specified major defects |
| D829 | Immunodeficiency associated with major defect, unspecified |
| D830 | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D831 | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
| D832 | Common variable immunodeficiency with autoantibodies to B- or T-cells |
| D838 | Other common variable immunodeficiencies |
| D839 | Common variable immunodeficiency, unspecified |
| D840 | Lymphocyte function antigen-1 [LFA-1] defect |
| D8481 | Immunodeficiency due to conditions classified elsewhere |
| D84821 | Immunodeficiency due to drugs |
| D84822 | Immunodeficiency due to external causes |
| D8489 | Other immunodeficiencies |
| D849 | Immunodeficiency, unspecified |
| D893 | Immune reconstitution syndrome |
| D8940 | Mast cell activation, unspecified |
| D8941 | Monoclonal mast cell activation syndrome |
| D8942 | Idiopathic mast cell activation syndrome |
| D8943 | Secondary mast cell activation |
| D8949 | Other mast cell activation disorder |
| D8982 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D8984 | IgG4-related disease |
| D8989 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D899 | Disorder involving the immune mechanism, unspecified |
| PDX Collection 6282 | |
| D800 | Hereditary hypogammaglobulinemia |
| D803 | Selective deficiency of immunoglobulin G [IgG] subclasses |
| D804 | Selective deficiency of immunoglobulin M [IgM] |
| D805 | Immunodeficiency with increased immunoglobulin M [IgM] |
| D806 | Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia |
| D807 | Transient hypogammaglobulinemia of infancy |
| D808 | Other immunodeficiencies with predominantly antibody defects |
| D809 | Immunodeficiency with predominantly antibody defects, unspecified |
| D810 | Severe combined immunodeficiency [SCID] with reticular dysgenesis |
| D811 | Severe combined immunodeficiency [SCID] with low T- and B-cell numbers |
| D812 | Severe combined immunodeficiency [SCID] with low or normal B-cell numbers |
| D814 | Nezelof's syndrome |
| D816 | Major histocompatibility complex class I deficiency |
| D817 | Major histocompatibility complex class II deficiency |
| D8182 | Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D8189 | Other combined immunodeficiencies |
| D819 | Combined immunodeficiency, unspecified |
| D820 | Wiskott-Aldrich syndrome |
| D821 | Di George's syndrome |
| D822 | Immunodeficiency with short-limbed stature |
| D823 | Immunodeficiency following hereditary defective response to Epstein-Barr virus |
| D824 | Hyperimmunoglobulin E [IgE] syndrome |
| D828 | Immunodeficiency associated with other specified major defects |
| D829 | Immunodeficiency associated with major defect, unspecified |
| D830 | Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function |
| D831 | Common variable immunodeficiency with predominant immunoregulatory T-cell disorders |
| D832 | Common variable immunodeficiency with autoantibodies to B- or T-cells |
| D838 | Other common variable immunodeficiencies |
| D839 | Common variable immunodeficiency, unspecified |
| D840 | Lymphocyte function antigen-1 [LFA-1] defect |
| D8481 | Immunodeficiency due to conditions classified elsewhere |
| D84821 | Immunodeficiency due to drugs |
| D84822 | Immunodeficiency due to external causes |
| D8489 | Other immunodeficiencies |
| D849 | Immunodeficiency, unspecified |
| D893 | Immune reconstitution syndrome |
| D8940 | Mast cell activation, unspecified |
| D8941 | Monoclonal mast cell activation syndrome |
| D8942 | Idiopathic mast cell activation syndrome |
| D8943 | Secondary mast cell activation |
| D8949 | Other mast cell activation disorder |
| D8982 | Autoimmune lymphoproliferative syndrome [ALPS] |
| D8984 | IgG4-related disease |
| D8989 | Other specified disorders involving the immune mechanism, not elsewhere classified |
| D899 | Disorder involving the immune mechanism, unspecified |
| PDX Collection 6283 | |
| E0940 | Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified |
| E0941 | Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy |
| E0942 | Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy |
| E0943 | Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy |
| E0944 | Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy |
| E0949 | Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication |
| E1040 | Type 1 diabetes mellitus with diabetic neuropathy, unspecified |
| E1041 | Type 1 diabetes mellitus with diabetic mononeuropathy |
| E1042 | Type 1 diabetes mellitus with diabetic polyneuropathy |
| E1043 | Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E1044 | Type 1 diabetes mellitus with diabetic amyotrophy |
| E1049 | Type 1 diabetes mellitus with other diabetic neurological complication |
| E1140 | Type 2 diabetes mellitus with diabetic neuropathy, unspecified |
| E1141 | Type 2 diabetes mellitus with diabetic mononeuropathy |
| E1142 | Type 2 diabetes mellitus with diabetic polyneuropathy |
| E1143 | Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E1144 | Type 2 diabetes mellitus with diabetic amyotrophy |
| E1149 | Type 2 diabetes mellitus with other diabetic neurological complication |
| E1340 | Other specified diabetes mellitus with diabetic neuropathy, unspecified |
| E1341 | Other specified diabetes mellitus with diabetic mononeuropathy |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 01 Mar 2023 06:12:40 CMS, code-revision=344, description-revision=1357 |